Cited by — Gedatolisib for the treatment of hormone receptor-positive/HER2-negative advanced breast cancer: a European perspective | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Gedatolisib for the treatment of hormone receptor-positive/HER2-negative advanced breast cancer: a European perspective.
No admitted local citation edges point to this work yet.
